May 17, 2019 - Top Gainers: GILD +3.1%. NOG +3.2%. NBRV +2.7%. GOL +2.3%. NIO +1%.Top Losers: LTM -4.7%. SIGA -1.9%. NKTR -1.8%. NVO -1.7%. ZYNE -1.7%.
May 10, 2019 - Allergan (AGN) and Novo Nordisk (NVO) announce Q1 results. Novartis buys rights to Takeda's dry eye disease drug, Xiidra.
May 09, 2019 - Oral semaglutide is on its way.
May 03, 2019 - Novo Nordisk A/S (NYSE:NVO) Q1 2019 Results Conference Call May 03, 2019 07:00 AM ET Company Participants Lars Fruergaard Jørgensen - CEO Karsten Munk Knudsen - CFO Mads Krogsgaard Thomsen - Chief Sci
May 03, 2019 - NVO earnings call for the period ending March 31, 2019.
May 02, 2019 - AEterna (AEZS) may provide update on the path forward for Macrilen in Europe on the first-quarter earnings call.
May 02, 2019 - Novo Nordisk (NVO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
May 01, 2019 - Allergan's (AGN) key products like Botox are likely to provide top-line support in Q1 as loss of exclusivity of several products hurts sales
Apr 30, 2019 - ANI Pharmaceuticals (ANIP) will provide updates on product launches, when it releases first-quarter 2019 results.
Apr 30, 2019 - BioSpecifics Technologies (BSTC) will provide updates on Xiaflex and pipeline progress, when it releases first-quarter 2019 results.